Terminally Exhausted CD8+ T Cells Resistant to PD-1 Blockade Promote Generation and Maintenance of Aggressive Cancer Stem Cells
Authors:
- Mohona ChakravartiMCMohona Chakravarti
- Sukanya DharSDSukanya Dhar
- Saurav BeraSBSaurav Bera
- Abhipsa SinhaASAbhipsa Sinha
- Kamalika RoyKRKamalika Roy
- Anirban SarkarASAnirban Sarkar
- Shayani DasguptaSDShayani Dasgupta
- Avishek BhuniyaABAvishek Bhuniya
- Akata SahaASAkata Saha
- Juhina DasJDJuhina Das
- Saptak BanerjeeSaptak Banerjee
- Manisha VernekarMVManisha Vernekar
- 27 March 2023
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 83 (11) , 1815-1833
Abstract
Heterogeneity within the tumor-infiltrating lymphocytes (TIL) population limits immunotherapeutic efficacy against cancer. Between two subpopulations of exhausted CD8+ TILs (progenitor-exhausted; TPEX, terminally exhausted; TTEX), TTEX cells remain unresponsive to anti–programmed cell death protein 1(PD-1) therapy. Deciphering whether and how PD-1–resistant TTEX cells engage in tumor promotion could improve the response to immunotherapy. Here, we report that TTEX cells actively participate in tumor progression by modulating cancer stem cells (CSC). TTEX cells strongly correlated with elevated CSC frequency in poorly immune-infiltrated (CD8+ TIL low) advanced human breast and ovarian carcinomas. TTEX directly upregulated CSC frequency in vitro, which was not affected by anti–PD-1 treatment. The TTEX-influenced CSCs were highly clonogenic and exhibited a multidrug-resistant phenotype, overexpressing drug efflux pumps like ABCC1 and ABCB1. These CSCs were highly invasive, displaying increased invadopodia development and elevated cofilin, CXCR4, and matrix metalloproteinase 7 (MMP7) expression. The invasive properties along with epithelial–mesenchymal plasticity of TTEX-educated CSCs increased metastasis in vivo. TTEX increased cell surface levels and activation of VEGFR2 in CSCs, and silencing or inhibition of VEGFR2 reversed the CSC-stimulatory effects of TTEX. LAMP3 and NRP1 on the surface of TTEX stimulated VEGFR2 in CSCs to promote aggressiveness. Cumulatively, these findings suggest that screening patients with carcinoma for both CD8+ TILs and TTEX frequency prior to anti–PD-1 therapy could improve patient outcomes. In addition, targeting the LAMP3/NRP1–VEGFR2 axis could be a therapeutic strategy in advanced patients with carcinoma with limited CD8+ T-cell infiltration and high TTEX frequency. Significance: Cross-talk with TTEX CD8+ T cells mediated by the VEGFR2 axis induces aggressive properties in cancer stem cells to promote tumor progression.Keywords
All Related Versions
Funding Information
- Indian Council of Medical Research (61/1/2019-BMS)
This publication has 63 references indexed in Scilit:
- ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinomaLaboratory Investigation, 2014
- The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesisNature Cell Biology, 2014
- Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapyCell Death & Differentiation, 2014
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal CounterpartsStem Cell Reports, 2014
- Contribution of cancer stem cells to tumor vasculogenic mimicryProtein & Cell, 2011
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like stateProceedings of the National Academy of Sciences, 2011
- Cancer stem cells and angiogenesisThe International Journal of Developmental Biology, 2011
- Nuclear expression of CXCR4 is associated with advanced colorectal cancerInternational Journal of Colorectal Disease, 2010
- Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cellsBrain Research, 2010
- Efficient Killing of Human Colon Cancer Stem Cells by γδ T LymphocytesThe Journal of Immunology, 2009